Zureikat Amer H, Postlewait Lauren M, Liu Yuan, Gillespie Theresa W, Weber Sharon M, Abbott Daniel E, Ahmad Syed A, Maithel Shishir K, Hogg Melissa E, Zenati Mazen, Cho Clifford S, Salem Ahmed, Xia Brent, Steve Jennifer, Nguyen Trang K, Keshava Hari B, Chalikonda Sricharan, Walsh R Matthew, Talamonti Mark S, Stocker Susan J, Bentrem David J, Lumpkin Stephanie, Kim Hong J, Zeh Herbert J, Kooby David A
*Division of Surgical Oncology, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA †Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute ‡Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA §Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison ¶Department of Surgery, University of Cincinnati, Cincinnati ||Department of Surgery, Cleveland Clinic Foundation, Cleveland, OH **Department of Surgery, NorthShore University Health System, Evanston ††Department of Surgery, Northwestern Memorial Hospital, Chicago, IL ‡‡Department of Surgery, University of North Carolina, Chapel Hill.
Ann Surg. 2016 Oct;264(4):640-9. doi: 10.1097/SLA.0000000000001869.
Limited data exist comparing robotic and open approaches to pancreaticoduodenectomy (PD). We performed a multicenter comparison of perioperative outcomes of robotic PD (RPD) and open PD (OPD).
Perioperative data for patients who underwent postlearning curve PD at 8 centers (8/2011-1/2015) were assessed. Univariate analyses of clinicopathologic and treatment factors were performed, and multivariable models were constructed to determine associations of operative approach (RPD or OPD) with perioperative outcomes.
Of the 1028 patients, 211 (20.5%) underwent RPD (4.7% conversions) and 817 (79.5%) underwent OPD. As compared with OPD, RPD patients had higher body mass index, rates of prior abdominal surgery, and softer pancreatic remnants, whereas OPD patients had a higher percentage of pancreatic ductal adenocarcinoma cases, and greater proportion of nondilated (<3 mm) pancreatic ducts. On multivariable analysis, as compared with OPD, RPD was associated with longer operative times [mean difference = 75.4 minutes, 95% confidence interval (CI) 17.5-133.3, P = 0.01], reduced blood loss (mean difference = -181 mL, 95% CI -355-(-7.7), P = 0.04) and reductions in major complications (odds ratio = 0.64, 95% CI 0.47-0.85, P = 0.003). No associations were demonstrated between operative approach and 90-day mortality, clinically relevant postoperative pancreatic fistula and wound infection, length of stay, or 90-day readmission. In the subset of 522 (51%) pancreatic ductal adenocarcinomas, operative approach was not a significant independent predictor of margin status or suboptimal lymphadenectomy (<12 lymph nodes harvested).
Postlearning curve RPD can be performed with similar perioperative outcomes achieved with OPD. Further studies of cost, quality of life, and long-term oncologic outcomes are needed.
关于机器人辅助与开放手术治疗胰十二指肠切除术(PD)的对比数据有限。我们对机器人辅助胰十二指肠切除术(RPD)和开放胰十二指肠切除术(OPD)的围手术期结果进行了多中心比较。
评估了在8个中心(2011年8月至2015年1月)完成学习曲线后的患者的围手术期数据。对临床病理和治疗因素进行单因素分析,并构建多变量模型以确定手术方式(RPD或OPD)与围手术期结果之间的关联。
1028例患者中,211例(20.5%)接受了RPD(4.7%中转开腹),817例(79.5%)接受了OPD。与OPD相比,RPD患者的体重指数更高、既往腹部手术率更高、胰腺残端质地更软,而OPD患者的胰腺导管腺癌病例百分比更高、胰腺导管未扩张(<3mm)的比例更大。多变量分析显示,与OPD相比,RPD的手术时间更长[平均差异=75.4分钟,95%置信区间(CI)17.5 - 133.3,P = 0.01],失血量减少(平均差异=-181mL,95%CI -355 - (-7.),P = 0.04),主要并发症减少(比值比=0.64,95%CI 0.47 - 0.85,P = 0.003)。手术方式与90天死亡率、临床相关的术后胰瘘和伤口感染、住院时间或90天再入院率之间未显示出关联。在522例(51%)胰腺导管腺癌亚组中,手术方式不是切缘状态或淋巴结清扫不充分(<12枚淋巴结)的显著独立预测因素。
学习曲线后的RPD可取得与OPD相似的围手术期结果。需要进一步研究成本、生活质量和长期肿瘤学结果。